Evidence map›Paper›PMID 35209034›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis.

Aamal A Al-Mutairi, Hend N Hafez, Abdel-Rhaman B A El-Gazzar, Marwa Y A Mohamed

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Nucleophile-induced ring contraction in pyrrolo[2,1-Beilstein journal of organic chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Aamal A Al-MutairiChemistry Department, Faculty of Science, Saudi Arabia; Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia.
Hend N HafezHeterocyclic & Nucleosides Unit, Photochemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.ORCID 0000-0003-1541-8744
Abdel-Rhaman B A El-GazzarHeterocyclic & Nucleosides Unit, Photochemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.
Marwa Y A MohamedBiology Department, Faculty of Science, Saudi Arabia; Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia.
Imam Mohammad ibn Saud Islamic University · SANational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our attempt towards the synthesis and development of effective antimicrobial, anticancer and antioxidant agents, a novel series of 2,3-dihydropyrido[2,3-d]pyrimidin-4-one

Indexed as

Anti-Infective AgentsAntineoplastic AgentsAntioxidantsBenzothiazolesMicrowavesBacteriaDrug Screening Assays, AntitumorFungiHCT116 CellsHep G2 CellsHumansMicrobial Sensitivity TestsAnti-Infective AgentsAntineoplastic AgentsAntioxidantsBenzothiazolesanticancerantimicrobialantioxidant activityarylidenesmicrowavepyrido[2,3-d]pyrimidinepyrrolo[2,1-b][1,3]benzothiazole

Identifiers

PMID35209034
PMCPMC8880104
OpenAlexW4213280356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.